Literature DB >> 10470717

The burden of disease among the global poor.

D R Gwatkin1, M Guillot, P Heuveline.   

Abstract

BACKGROUND: Global and regional estimates show that non-communicable diseases in old age are rising in importance relative to other causes of ill health as populations age, and as progress continues against communicable diseases among infants and children. However, these estimates, which cover population groups at all income levels, do not accurately reflect conditions that prevail among the poor. We estimated the burden of disease among the 20% of the global population living in countries with the lowest per capita incomes, compared with the 20% of the world's people living in the richest countries.
METHODS: Estimates for the global poorest and richest 20% were prepared for 1990 for deaths and disability-adjusted life years (DALYs), by a procedure used in a prominent recent study of the global disease burden. Projected mortality rates in the year 2020 were established for the world's poorest and richest 20% under various assumptions about the future rate of decline in communicable and non-communicable diseases.
FINDINGS: In 1990, communicable diseases caused 59% of death and disability among the world's poorest 20%. Among the world's richest 20%, on the other hand, non-communicable diseases caused 85% of death and disability. A raised baseline rate of communicable disease decline between 1990 and 2020 would increase life-expectancy among the world's poorest 20% around ten times as much as it would the richest 20% (4.1 vs 0.4 years). However, the poorest 20% would gain only around a quarter to a third as much as the richest 20% from a similar increase in non-communicable diseases (1.4 vs 5.3 years). As a result, a faster decline in communicable diseases would decease the poor-rich gap in 2020, but under an accelerated rate of overall decline in non-communicable diseases, the poor-rich gap would widen.
INTERPRETATION: Our estimates are crude, but despite their limitations, they give a more accurate picture of changes in attributable mortality among the world's poor than do the global averages in current use.

Entities:  

Keywords:  Comparative Studies; Death Rate; Demographic Factors; Diseases; Economic Factors; High Income Population; Low Income Population; Morbidity; Mortality; Population; Population Dynamics; Research Methodology; Research Report; Social Class; Socioeconomic Factors; Socioeconomic Status; Studies; World

Mesh:

Year:  1999        PMID: 10470717     DOI: 10.1016/S0140-6736(99)02108-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  50 in total

1.  Vaccines and medicines for the world's poorest. Public-private partnerships seem to be essential.

Authors:  R Smith
Journal:  BMJ       Date:  2000-04-08

2.  Neglected diseases: under-funded research and inadequate health interventions. Can we change this reality?

Authors:  Carlos M Morel
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

3.  Is it time to reassess the categorization of disease burdens in low-income countries?

Authors:  Philip W Setel; Lance Saker; Nigel C Unwin; Yusuf Hemed; David R Whiting; Henry Kitange
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

4.  Towards the prevention and management of prostatic diseases in Nigeria: a framework.

Authors:  Chukwunonso Ecc Ejike
Journal:  Malays J Med Sci       Date:  2011-07

5.  Commentary: Poverty and cardiovascular disease in India: do we need more evidence for action?

Authors:  Dorairaj Prabhakaran; Panniyammakal Jeemon; Kolli Srinath Reddy
Journal:  Int J Epidemiol       Date:  2013-08-06       Impact factor: 7.196

6.  Is the scale up of malaria intervention coverage also achieving equity?

Authors:  Richard W Steketee; Thomas P Eisele
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

7.  An Antipoverty Agenda for Public Health: Background and Recommendations.

Authors:  Jeff Levin
Journal:  Public Health Rep       Date:  2017-05-24       Impact factor: 2.792

Review 8.  Parasites and poverty: the case of schistosomiasis.

Authors:  Charles H King
Journal:  Acta Trop       Date:  2009-12-04       Impact factor: 3.112

9.  A typology of intellectual property management for public health innovation and access: design considerations for policymakers.

Authors:  Antony Taubman
Journal:  Open AIDS J       Date:  2010-01-19

10.  The uneven tides of the health transition.

Authors:  Patrick Heuveline; Michel Guillot; Davidson R Gwatkin
Journal:  Soc Sci Med       Date:  2002-07       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.